Activated omentum slows progression of CKD

Area of Science:

• Nephrology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Stem cell therapy shows potential for acute kidney injury (AKI) but faces challenges with long-term survival post-injection.
• Omentum, a source of stem cells, has been used to promote organ repair when attached to damaged organs.
• Chronic kidney disease (CKD) progression remains a significant clinical challenge, necessitating innovative therapeutic strategies.

Purpose of the Study:

• To investigate if fusing the omentum to a subtotally nephrectomized kidney could impede CKD progression.
• To explore the potential of omental stem cells and their secretory products in renal repair.

Main Methods:

• A rat model of 5/6 nephrectomy was used, with experimental groups receiving omentum fusion and controls undergoing omentectomy.
• Polydextran gel particles facilitated omentum-kidney fusion in the experimental group.
• Histological, biochemical, and molecular analyses were performed after 12 weeks to assess kidney health and repair markers.

Main Results:

• Experimental rats with fused omentum showed significantly lower plasma creatinine and urea nitrogen levels compared to controls.
• Reduced glomerulosclerosis, tubulointerstitial injury, extracellular matrix deposition, and basement membrane thickening were observed in the experimental group.
• The omentum-kidney fusion zone revealed abundant stem cells (expressing CD34, stem cell antigen-1, WT-1) and increased renal repair growth factors and proliferating cells.

Conclusions:

• Omentum contact with injured kidneys effectively slows CKD progression in remnant organs.
• Omental stem cells and their secreted factors appear to mediate the observed renal protective and regenerative effects.
• This study presents a promising strategy for managing CKD through omentum-based regenerative therapy.